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Background: Over 30 % of older patients experience hospitalization-associated disability (HAD) (i.e., loss of
independence in Activities of Daily Living (ADLs)) after an acute hospitalization. Despite its high prevalence,
the mechanisms that underlie HAD remain elusive. This paper describes the protocol for the Hospital-Associated
Disability and impact on daily Life (Hospital-ADL) study, which aims to unravel the potential mechanisms behind HAD
from admission to three months post-discharge.
Methods/design: The Hospital-ADL study is a multicenter, observational, prospective cohort study aiming to recruit
400 patients aged ≥70 years that are acutely hospitalized at departments of Internal Medicine, Cardiology or Geriatrics,
involving six hospitals in the Netherlands. Eligible are patients hospitalized for at least 48 h, without major cognitive
impairment (Mini Mental State Examination score ≥15), who have a life expectancy of more than three months, and
without disablement in all six ADLs. The study will assess possible cognitive, behavioral, psychosocial, physical, and
biological factors of HAD. Data will be collected through: 1] medical and demographical data; 2] personal interviews,
which includes assessment of cognitive impairment, behavioral and psychosocial functioning, physical functioning, and
health care utilization; 3] physical performance tests, which includes gait speed, hand grip strength, balance, bioelectrical
impedance analysis (BIA), and an activity tracker (Fitbit Flex), and; 4] analyses of blood samples to assess inflammatory
and metabolic markers. The primary endpoint is additional disabilities in ADLs three months post-hospital discharge
compared to ADL function two weeks prior to hospital admission. Secondary outcomes are health care utilization,
health-related quality of life (HRQoL), physical performance tests, and mortality. There will be at least five data collection
points; within 48 h after admission (H1), at discharge (H3), and at one (P1; home visit), two (P2; by telephone) and three
months (P3; home visit) post-discharge. If the patient is admitted for more than five days, additional measurements will
be planned during hospitalization on Monday, Wednesday, and Friday (H2).
Discussion: The Hospital-ADL study will provide information on cognitive, behavioral, psychosocial, physical, and
biological factors associated with HAD and will be collected during and following hospitalization. These data may
inform new interventions to prevent or restore hospitalization-associated disability.
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Studies have observed that at least 30 % of older patients
hospitalized with an acute medical illness show a persist-
ent decline in their ability to maintain Activities of Daily
Living (ADLs) [1–5]. Such activities are prerequisites to
self-care and independent living and include bathing,
dressing, transferring out of bed, eating, toileting, and be-
ing mobile in and around the house. [1, 3–7]. This decline
has been denoted hospitalization-associated disability
(HAD), and is defined as the loss of ability to perform one
or more of the basic ADLs [6].
HAD is an important problem; it is the leading cause of
loss of independence at older age [4] and it is a complex
and highly dynamic process with possible recurrent dis-
ability episodes in older patients [6, 8]. Research shows
that older persons who have been hospitalized have a 60-
fold increased risk to develop permanent disabilities [9].
The first month after hospital discharge has been identi-
fied as a critical period for recovery, after which disabilities
have a high risk of becoming permanent [3]. Moreover,
patients with new disabilities are at high risk for other ad-
verse outcomes within three months post discharge: 20 %
have readmissions [10], and post-discharge mortality is
25 % [1, 3, 11, 12]. In light of the high prevalence in older
patients, and the rapid aging of western societies with a
concomitant rise in hospitalizations, a better understand-
ing of HAD is urgently needed.
Previous research has been able to identify a number
of generic risk factors for hospitalization-associated dis-
ability such as older age [5], the severity of acute illness,
geriatric conditions, cognitive impairment and delirium
[1, 6, 13, 14]. However, a more fine-grained analyses and
characterization of potentially modifiable risk factors is
virtually absent from the literature. Little is known, for
example, about: 1] the course of loss of muscle mass and
strength, and the amount of physical activity older patients
perform; 2] the association of cognitive, (psycho-)somatic,
behavioral, and psychological restrictive symptoms with the
onset and recovery from HAD within the critical period of
three months post-discharge such as cognitive impairment,
fatigue, pain, sleep quality, shortness of breath, dizziness,
fear of falling, diminished self-efficacy, apathy, depression,
and anxiety and; 3] the association of the inflammatory ac-
tivity and related sickness behaviors with the onset and re-
covery from HAD. Moreover, most previous studies have
utilized relatively long follow-up intervals (e.g., from admis-
sion to three months or more) [1–3, 15]. Thus information
is lacking on events and processes that take place during
the weeks after discharge, which are thought to be critical
to recovery.
The current study – Hospital-Associated Disability and
impact on daily Life (Hospital-ADL study) – aims to inves-
tigate cognitive, behavioral, psychosocial, physical, and bio-
logical factors that may be associated with HAD in acutelyhospitalized older adults, performing frequent assess-
ments to capture their dynamic development from hos-
pital admission to three months post-discharge. This
overall aim can be separated into the following five sub-
ordinate aims:
(1)To study the temporal profile of HAD (i.e., loss
of ADL) from hospitalization to three months
post-discharge.
(2)To investigate the course of physical functions that
are essential to support ADL, such as muscle mass,
muscle strength, and physical performance and
spontaneous activity, and test its predictive value for
the onset and recovery from HAD, health care
utilization, and health-related quality of life (HRQoL)
at three months post-discharge.
(3)To study the prevalence, incidence and course of
cognitive, (psycho-)somatic, behavioral, and
psychological problems older patients experience
from hospitalization up to three months post-discharge
that might be restrictive in recovery from HAD
post-discharge such as cognitive impairment, fatigue,
pain, sleep quality, shortness of breath, dizziness, fear
of falling, diminished self-efficacy, apathy, depression,
and anxiety.
(4)To study the association of aforementioned symptoms
with HAD, health care utilization, and HRQoL.
(5)To study the association of metabolic and
proinflammatory factors, and physical and
behavioral concomitants (e.g., sickness behaviors,
loss of muscle mass) with the onset of and recovery
from HAD, health care utilization, and HRQoL.Methods/Design
Study design and setting
The Hospital-ADL study is a multicenter, observational,
prospective cohort study designed by an interdisciplin-
ary team of researchers in the field of geriatrics, nurs-
ing, psychology, physical therapy and rehabilitation. Six
hospitals will participate: 1] the Academic Medical
Center in Amsterdam (AMC), a 1002-bed university
teaching hospital; 2] the Isala in Zwolle, a 994-bed re-
gional teaching hospital; 3] the Tergooi in Blaricum, a
regional teaching hospital (633-bed spread over two
sites: Hilversum and Blaricum); 4] the Slotervaart Hos-
pital in Amsterdam, a 310-bed regional teaching hos-
pital; 5] the BovenIJ Hospital in Amsterdam, a 313-bed
regional teaching hospital, and; 6] the Meander Medical
Center in Amersfoort, a 543-bed regional teaching hos-
pital. The study has started October 1, 2015 and will
end after the last patient has been followed up for three
months post-discharge. We expect the recruitment
phase to be completed late 2016.
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We aim to recruit 400 non-fully disabled adults aged
≥70 years. The following inclusion criteria apply: 1]
acutely admitted at departments of Internal Medicine,
Cardiology or Geriatrics for 48 h or more in one of the
above mentioned hospitals; 2] 70 years and older; 3]
have approval from the attending Medical Doctor for in-
clusion; 4] score of 15 or higher on the Mini-Mental
State Examination; 5] Dutch language proficiency suffi-
cient to complete questionnaires. Patients will be ex-
cluded if they: 1] have a life expectancy of three months
or less as assessed by the attending Medical Doctor, or;
2] are disabled in all six basic ADL as determined by the
Katz-ADL index [16].
Procedures
Eligible patients will be contacted, and the patient will
be informed about the objectives of this study and the
study procedures, upon which written informed consent
is obtained. Furthermore, a legal representative of the
patient will be contacted if the patient has a MMSE
score between 15 and 20. Two mobile geriatric assess-
ment teams will visit all six hospitals and will be present
on Monday, Wednesday and Friday for consenting and
to perform assessments. The mobile geriatric assessment
teams consist of a psychologist, physical therapist, and/
or a health scientist. The teams are trained in the study
procedures of obtaining informed consent, to perform
assessments and physical performance tests with ad-
equate inter- and intra-rater reliability (>0.8), and com-
pleting the electronic case report form (eCRF).
Table 1 provides an overview of the location, content of
assessment and duration of data collection per time point.
There will be at least five data collection points; within
48 h after admission (H1), at discharge (H3), and at one
(P1; home visit), two (P2; by telephone) and three months
(P3; home visit) post-discharge. If the patient is admitted
for more than five days, additional measurements will be
planned during hospitalization on Monday, Wednesday,
and Friday (i.e., the days that the mobile geriatric assess-
ment team is present) (H2),
Data will be collected through: 1] medical and demo-
graphical data (e.g., socio-demographic characteristics,
severity of acute illness, and geriatric-, and chronic
conditions); 2] personal interviews (including cognitive,
behavioral, psychosocial, and physical parameters, and
health care utilization, see description of information
collected below); 3] physical performance tests (e.g.,
gait speed, muscle strength, muscle mass, mobility and
physical functioning, see below) and; 4] blood samples
(e.g., to assess markers of inflammation).
The personal interviews will take place during
hospitalization (H1, H2, and H3), at the participant’s
home or residence (P1 and P3; one and three monthspost-discharge), and by telephone (P2; two months post-
discharge). Physical performance data will be collected
within 48 h after admission (H1), during hospitalization
on Monday, Wednesday and Friday (H2), at discharge
(H3), and at one and three months post-discharge (P1
and P3).
Primary outcome
The primary outcome is the level of ADL functioning
three months post-discharge compared to premorbid
functioning, which are measured with the 6-item Katz-
ADL index score of the modified Katz-ADL index [17].
The Katz-ADL index score assesses the degree of inde-
pendence in bathing, dressing, toileting, use of incontin-
ence materials, transfer from bed-chair and eating [16].
Secondary outcomes
Secondary outcomes include:
(1)Health care utilization (extension of the Minimal
Dataset (MDS) [18] and Comprehensive Geriatric
Assessment of the Transitional Care Bridge (TCB)
[19], see below).
(2)Quality of life as measured with the EuroQol-5D [20]
and the three items of the MDS [18] (see description
below).




Table 2 gives a detailed overview of the primary and sec-
ondary outcomes at each time point.
(1)Medical and demographical data
Socio-demographic characteristics. Socio-demographic
data include age, gender, date and time of admission,
highest level of education, ethnicity, marital status
and living arrangement.
Geriatric conditions. A comprehensive geriatric
assessment (CGA) will be collected, which will
provide insight in the pre-illness determinants such
as polypharmacy, substance use, incontinence, and
vision- and hearing impairments.
Chronic conditions. The number and severity of
comorbidities will be scored with the Charlson
Comorbidity Index [21]. Depending on the risk of
mortality, each condition is assigned a score of 1,
2, 3, or 6. Higher scores indicate a greater risk of
mortality.
Severity of acute illness. The severity of the acute
illness will be measured with the Modified Early
Warning Score (MEWS). The MEWS is based on 1]
respiratory rate; 2] heart rate; 3] systolic and
Table 1 Time, location, content of assessment and duration of the Hospital-ADL study
Time Location Content of assessment Duration (minutes)








Behavioral & psychosocial functioning
Health care utilization (medical record)
Physical performance tests
Blood parameters
H2 (During hospital stay on
Monday-Wednesday-Friday)
Hospital Medical & demographical data 20–30
Severity of acute illness (medical record)
Short personal interview/self-report data
Physical performance tests
Blood parameters
H3 (At hospital discharge) Hospital Personal interview/self-report data 40
Cognitive functioning
ADL/Physical functioning
Behavioral and psychosocial functioning
Physical performance tests
Blood parameters






Behavioral & psychosocial functioning
Health care utilization
Physical performance tests
P2 (Two months post-discharge) By telephone Personal interview/self-report data 20
ADL/physical functioning
Behavioral and psychosocial functioning
Health care utilization
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Table 2 Summary of outcome measures and time points of assessment in Hospital-ADL study
Question or instrument H1 H2 H3 P1 P2 P3
1. Medical & demographical data
Age Date of birth ×*
Gender ×
Postal code ×
Date and time of admission ×*
Education (In accordance with Verhage, 1966 [57]) ×
Ethnicity Country of birth patient and parents ×
Marital status [18] ×
Living arrangement [18, 19] × × ×
Medical comorbidity CCI [21] ×*
Severity of acute illness MEWS [22] ×* ×* ×*
Admission diagnosis ×*
2. Personal interviews/self-report data
2.1 Cognitive functioning
Cognitive impairment MMSE [23] × × × ×
Delirium CAM [24, 58] ×
Assessing whether: 1] the patient needs help with self-care; 2]
the patient has previously undergone a delirium and; 3] the
patient has a cognitive impairment [25]
×*
2.2 Behavioral & psychosocial functioning
Fear of falling NRS fear of falling × × × × × ×
Anxiety STAI-6 [31] × × × × ×
Apathy GDS-15 [29] × × × × ×
General self-efficacy ALCOS-12 [34] × × ×
Quality of life 1] In general, how is your quality of life?; 2] How would you grade
your life at this moment, with a range between 0 and 10? and; 3]
Compared to one year ago, how would you rate your health in
general now? [18]
× × × × ×
EQ-5D [20] × × × × ×
2.3 ADL/Physical functioning
Disability in ADLs Modified Katz Index Scale [16, 17] × × × × ×
Independency in walking FAC [42] × × × × × ×
Mobility Could you walk outside for 5 minutes two weeks before admission/
currently? And how often did/do you do physical activity two
weeks before admission/currently? [19]
× × × × ×
Falls Have you fallen once or more in the past (six) month(s)? If yes,
how many times? [25]
× × × × ×
Pain NRS pain [35] × × × × × ×
Fatigue NRS fatigue [37] × × × × × ×
Impact of fatigue MFIS-5 [38] × × ×
Sleep quality PSQI [39] × × × × ×
Sleep medication PSQI [39] × × × × ×
Daytime sleepiness Do you currently suffer from daytime sleepiness? If yes, does this
affect your daily living?
× × × × × ×
Polynocturia Do you currently suffer from polynocturia? If yes, does this affect
your daily living?
× × × × × ×
Dizziness Do you currently suffer from dizziness? If yes, does this affect
your daily living?
× × × × × ×
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Table 2 Summary of outcome measures and time points of assessment in Hospital-ADL study (Continued)
Shortness of breath Do you currently suffer from shortness of breath? If yes, does
this affect your daily living?
× × × ×× × ×
Hearing impairment Do you experience difficulties with hearing, despite the use of
a hearing aid?
× × ×
Vision impairment Do you experience difficulties with your vision, despite the use
of glasses?
× × ×
Nutrition SNAQ [25, 41] × × × × ×
Dependency Do you smoke? Do you use alcohol [19]? × × ×
Polypharmacy Do you use five or more different medications [19]? × × ×
2.4 Health care utilization
Readmission Have you been hospitalized in the last (six) month(s)? If yes, for
how many days? [18]
×* × × ×
Nursing home admission Have you had a nursing home admission in the last month? If yes, for how




Have you had a consultation with your physiotherapist and/or
occupational therapist in the last month? If yes, how many times?
× × ×
Consult general practitioner Have you had a consultation with your general practitioner in the
last month? If yes, in the evening, night or weekend and how
many times totally? [19]
× × ×
Home care Do you use home care? If yes, care assistance and/or domestic
help and how many hours per week [19]
× × ×
3. Physical performance tests
Handgrip strength Jamar® [59–61] × × × × ×
Mobility DEMMI [45] × × × × ×
Agility CSR [47] × × × × ×
Balance, strength, and gait SPPB [46] × × × × ×
Walking distance 2MWT [49] × × × × ×
Body composition BIA (Bodystat Quadscan 4000) [50] × × × × ×
Activity tracker Fitbit Flex [51] × × × × ×
Question or instrument H1 H2/H3 P1 P2 P3
4. Blood parameters
Inflammation markers CRP [52] × ×
WBC diff × ×
TNF-α [53–55] × ×
IL-6 [53–55] × ×
IL-8 [55] × ×
Mortality Date of death ×*
Note: H1 = within 48 h after admission; H2 = during hospitalization on Monday, Wednesday, and/or Friday; H3 = at discharge; P1 = one month post-discharge (home
visit); P2 = two months post-discharge (by telephone); P3 = three months post-discharge (home visit);
×* = Data will be obtained from medical record;
CCI Charlson Comorbidity Index, MEWS Modified Early Warning Score, MMSE Mini Mental State Examination, CAM Confusion Assessment Method, NRS Numeric
Rating Scale, STAI-6 State Trait Anxiety Inventory-6, GDS-15 Geriatric Depression Scale-15, ALCOS-12 Algemene Competentie Schaal-12 (General Self-Efficacy Scale),
EQ-5D EuroQol-5D, FAC Functional Ambulation Categories, MFIS-5 Modified Fatigue Impact Scale-5, PSQI Pittsburgh Sleep Quality Index, SNAQ Short Nutritional
Assessment, DEMMI De Morton Mobility Index, CSR Chair Sit and Reach test, SPPB Short Physical Performance Battery, 2MWT 2 Minute Walking Test, BIA Bioelectrical
Impedance Analysis, CRP C-Reactive Protein, WBC diff White Blood Cell Differential, TNF-α Tumor Necrosis Factor-α, IL-6 Interleukin-6, IL-8 Interleukin-8
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temperature, and; 6] oxygen saturation [22].
Personal interviews/self-report data
(2.1) Cognitive functioning
Cognitive impairments. The most commonly used
Mini Mental State Examination (MMSE) will beapplied to classify the severity of a cognitive
impairment. It is a validated 23-item screening of
cognitive impairment. The MMSE consists of a
series of questions and tests, which assess differ-
ent mental abilities, including memory, attention,
language, and planning. Cognitive impairment is
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[23].
Delirium. The Confusion Assessment Method (CAM)
will be used to identify the presence of delirium. The
CAM consists of four features: 1] acute onset and
fluctuating course; 2] inattention; 3] disorganized
thinking, and 4] altered level of consciousness. The
diagnosis of delirium requires the presence of both
features 1 and 2, and the presence of either feature 3 or
4 [24]. Furthermore, we want to assess the risk for
developing delirium with the following statements of
the Dutch Safety Management Programme
(Veiligheidsmanagementsysteem (VMS)): 1] the
patient needs help with self-care, 2] the patient has
previously undergone a delirium, and 3] the patient
has a cognitive impairment such as dementia [25, 26].
(2.2) Behavioral and psychosocial functioning
Fear of falling. A Numeric Rating Scale (NRS) will
be applied to measure fear of falling, in which a
participant selects a whole number (0–10 integers).
Zero represents no fear of falling and ten the worst
possible fear of falling.
Depression. The Geriatric Depression Scale-15
(GDS-15) will be used to measure symptoms of
depression (Cronbach’s α = 0.75 [27]). The GDS-15
is a self-report scale of 15 items on a binary (yes/no)
scale and assesses symptoms over the preceding week.
The total score is the sum of the 15 items (range 0–15
points, higher scores indicating more depression). The
following categories of the GDS-15 will be used: a
score of 0 to 4 will be considered ‘normal’, a score of 5
to 8 a ‘mild depression’, 9 to 11 a ‘moderate depression’,
and 12 to 15 a ‘severe depression’ [28].
Apathy. Three items of the GDS-15 will be used to
measure apathy (sensitivity of 69 % and specificity of
85 % [29]). The three apathy items include the
following questions: 1] “Do you prefer to stay at
home, rather than going out and doing new things?”;
2] “Have you dropped many of your activities and
interests?” and; 3] “Do you feel full of energy? Higher
scores indicate more apathy. A score of ≥2 points is
indicative for apathy [29].
Anxiety. The State-Trait Anxiety Inventory-6
(STAI-6) will be used to measure anxiety
symptoms (Cronbach’s α = 0.79-0.81 [30]). The
STAI-6 is a short-form of the 20-item state scale
of the Spielberger State-Trait Anxiety Inventory
(STAI) [31], that maintains results that are
comparable with this full-form [30]. It consists of
six items on a 4-point Likert scale (1] not at all/
almost never; 2] somewhat/sometimes; 3] moderately
so/often, and; 4] very much so/almost always).
Furthermore, it remains sensitive to different
levels of anxiety.Perceived self-efficacy. The General Self Efficacy
Scale (In Dutch: Algemene Competentie Schaal
(ALCOS-12)) will be used to measure general
perceived self-efficacy (Cronbach’s α = 0.78 [32]). It
is based on the Self-Efficacy Scale [33] and is a
Dutch translated self-report rating scale of 12 items
on a 5 point Likert scale (1] strongly disagree; 2]
disagree; 3] no disagreement/agreement; 4] agree
and; 5] strongly agree). The ALCOS-12 includes
three subscales: competence (Cronbach’s α = 0.72),
perseverance in adversity (Cronbach’s α = 0.67), and
taking initiative (Cronbach’s α = 0.74) [32]. The total
score is the sum of the 12 items (range 12–60),
whereby the following categories of the ALCOS-12
will be used: a score of 12 to 38 will be defined as a
‘low competence level’, a score of 39 to 54 as ‘average’
and 55 to 60 as ‘high’ [34].
Health-Related Quality of life. The EuroQol-5D
(EQ-5D), a widely used preference based generic
health-related quality of life (HRQoL) instrument
with well-established psychometric properties will be
administered [20]. The EQ-5D consists of five
dimensions: 1] mobility; 2] self-care; 3] usual
activities; 4] pain/discomfort and; 5] anxiety/
depression. These dimensions have three response
choices (no problems; some problems or; severe
problems). Moreover, the following questions will be
used to measure quality of life: 1] “In general, how is
your quality of life (participants answer the item with
one of five possible responses: excellent; very good;
good; moderate or; bad)?”; 2] “How would you grade
your life at this moment, with a range between 0 and
10?” and; 3] “Compared to one year ago, how would
you rate your health in general now (five response
choices: much better; slightly better; much the same;
slightly worse or; much worse)?” [18].
(2.3) Physical functioning
Dizziness, polynocturia and shortness of breath.
Symptoms of dizziness and shortness of breath will
be assessed by asking: “Do you suffer from
polynocturia/dizziness/shortness of breath at this
moment? If yes, does this affect your daily
functioning?”
Pain. A gold standard of pain intensity
measurements, the Numeric Rating Scale (NRS), will
be applied to measure pain. The NRS for pain is a
validated continuous scale with a score range
between 0 and 10 (0 represents no pain and 10 the
worst possible pain) [35, 36].
Fatigue. The Numeric Rating Scale (NRS), will be
used to measure fatigue. The NRS for fatigue is a
continuous scale with a score range between zero
and ten (zero represents no pain and ten the worst
possible fatigue) [37].
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21-item Modified Fatigue Impact Scale (MFIS) will
be used to quantify the impact of fatigue. The short
version consists of five items that are divided into
three subscales: physical- (2 items), cognitive- (2
items), and psychosocial functioning (1 item) subscale.
An example of a MFIS-5 statement is: “Because of my
fatigue during the past four week, I have been less
alert.” The total score of the MFIS-5 is the sum of the
raw scores on a 5-point Likert scale (0] never; 1] rarely;
2] sometimes; 3] often, and; 4] almost always). Higher
scores indicate greater fatigue [38].
Sleep. The Pittsburgh Sleep Quality Index (PSQI)
will be utilized to measure two components of sleep:
sleep quality and sleep medication. Sleep quality will
be quantified by asking: “During the past month,
how would you rate your sleep quality overall?”
Sleep medication will be measured by asking:
“During the past month, how often have you taken
medicine (prescribed or “over the counter”) to help
you sleep?” The score of sleep quality and sleep
medication have a range of 0 (better) to 3 (worse)
[39]. In addition, we measure daily sleepiness on a
binary scale (yes/no) with the following question:
“Do you currently suffer from daytime sleepiness? If
yes, does this affect your daily living?”
Nutrition. The widely used Short Nutritional
Assessment Questionnaire (SNAQ) will be applied
to identify malnourished hospital patients
(Cronbach’s alpha = 0.58 [40]) [25, 26]. The total
score of the SNAQ is the sum of the raw scores,
whereby the following categories of the SNAQ will
be used: a score of 0 to 1 will be defined as ‘no
malnutrition’, a score of 2 as ‘moderate malnutrition’
and a score of 3 as ‘severe malnutrition’ [41].
ADL functioning. The 15 items modified Katz-ADL
index will be used to measure physical functioning
[16, 17]. The modified Katz-ADL index consists of
statements of their independency in performing
basic Activities of Daily Living (ADL) and Instrumental
Activities of Daily Living (IADL) (formulated in two
versions on a binary (yes/no) scale: two weeks before
admission or currently).
Mobility. The Functional Ambulation Categories
(FAC) will be used to classify mobility, using six
categories: a category of 1 will be defined as
‘independent unlimited’, a category of 2 as ‘independent
limited’ and categories 3 to 5 as ‘dependent’. Allocation
to these last categories is based on levels of assistance
and supervision needed [42]. Furthermore, we will
measure mobility with two questions in according to
the Comprehensive Geriatric Assessment (CGA) of
the Dutch Society of Clinical Geriatrics (NVKG, 2012):
1] “Were you able to walk outside the house for fiveminutes (formulated in two versions: two weeks before
admission or currently)?”, and; 2] “How often did/do
you perform physical activity two weeks before
admission/currently [19]?”
Falls. To measure the number of falls in the past
(six) month(s) the following question of the VMS
will be used: “Have you fallen once or more in the
past (six) month(s)? If yes, how many times [25, 26]?”
(2.4) Health care utilization
(Re)admission(s). Any (re)admission(s) to the hospital
will be measured. We will search the medical record
for (re)admission(s) in the same hospital six months
before hospitalization and during three months
post-discharge, and we will also retrieve this
information by self-report at P1-P3 with the following
self-report question: “Have you been hospitalized in
the last month? If yes, for how many days [18]?” Data
that will be collected out of the hospital system are:
date of admission and discharge for any readmission,
whether the admission was planned or unplanned and
the reason for the readmission.
Nursing home admission(s). The amount of nursing
home admission or whether they were admitted to
the nursing home and the length of stay will be
measured with the subsequent question: “Have you
had a nursing home admission in the last month? If
yes, for how many weeks totally [18]?”
Consult of physical therapist and/or occupational
therapist. The amount of consults of a physiotherapist
and/or occupational therapist will be measured by
asking: “Have you had a consultation with your
physical therapist and/or occupational therapist in the
last month? If yes, how many times?”
Consult general practitioner. The amount of consults
of a general practitioner will be measured by asking:
“Have you had a consultation with your general
practitioner in the last month? If yes, in the evening,
night or weekend and how many times in total [19]?”
Home care. The use of home care will be measured
with the subsequent question: “Do you use home
care? If yes, care assistance and/or domestic help
and how many hours per week [19]?” A distinction
will be made between household help from a nursing
aid, and help from a registered nurse.
(2)Physical performance tests
Handgrip strength. The hand grip strength will be
measured with the widely used Jamar® grip strength
dynamometer (Lafayette Instrument Company,
USA). The handgrip strength test is used to provide
an objective index of general upper body strength.
Handgrip strength is a reliable instrument (good to
excellent test-retest reproducibility and excellent
inter-rater reliability) to indicate skeletal muscle mass
[43]. Participants will perform the task thrice with
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used and registered in the eCRF. Normative values of
adults are described in a study of Mathiowetz [44].
Mobility. To measure the mobility we will use the
15-item Morton Mobility Index (DEMMI). Subjects
will be asked to perform several mobility tasks, in
the order of bed, chair, stand, and walking activities
to maximize patient safety, which will result in an
ordinal raw score (range: 0–19). The ordinal raw
score will be converted into a total interval DEMMI
score (range: 0 to 100 points). Moreover, the DEMMI
has a hierarchical structure, and thus each assessed
participant can be evaluated. Higher scores indicate a
better mobility performance [45].
Balance, strength, and gait speed. The Short Physical
Performance Battery (SPPB) will be applied to
measure the balance, strength and gait speed.
Participants will be asked to stand with their feet in
various balance positions, walk a distance of four
meter and to rise from a chair and return to the
seated position five times as quickly as possible.
Higher scores indicate a better performance [46].
Back and hamstring flexibility. The Chair Sit and
Reach (CSR) test will be used as a measure of
flexibility. Participant will be asked to extend one leg
as straight as possible, hands on top of each other,
and then to reach to his/her foot as far as possible.
Lower distances between the tip of his/her toes and
their extended fingers indicating a higher back and
hamstring flexibility [47, 48].
Walking distance. The 2 Minute Walking West
(2MWT) will be applied to measure the maximal
walking distance in meters. Participants will be
asked to walk back and forth along a premeasured
corridor of 15 meter in two minutes. Longer
walking distances indicating a better walking
capacity [49].
Body composition. The Bioelectrical Impedance
Analysis (BIA) (Bodystat Quadscan 4000) will be
used as method for estimating body composition, in
particular fat-free mass (FFM) and high fat mass
(FM). Electrodes will be attached to the ankle and
wrist. A small electric signal will circulate, which
measures the resistance and reactance of this
electrical signal in the human body [50].
Activity level. The Fitbit Flex will be applied to
monitor the sleep quality, measure motion patterns,
determine the calories burned, distance traveled, and
steps taken [51]. Participants will be asked to wear
the Fitbit Flex from hospital admission up to one
and a half weeks post-discharge.
(3)Blood parameters
Inflammation markers. Inflammation markers, such
as C-Reactive Protein (CRP) [52], Tumor NecrosisFactor-α (TNF-α), the interleukins IL-6 [53–55] and
IL-8) [55], and White Blood Cell Differential (WBC
diff ), will be determined from blood plasma and
serum. Blood will be collected during the customary
laboratory rounds during hospitalization. Venous
blood will be collected in 4.5 ml EDTA and serum
vacutainers. Samples will be centrifuged and stored
at −80 C° until analysis. Sample handling and analyses
will be performed according to ISO standards.Planned statistical analyses
Data will be analyzed in accordance with the research
questions outlined in the introduction, applying appro-
priate General Linear Models (e.g., linear regression,
repeated measures ANOVA/ANCOVA) as well as log-
linear models (e.g., logistic regression in case of binary
outcomes). Mortality, a (censored) numerical outcome,
will be tested using survival analysis. The global α level
will be set at 0.05 with hypothesis-wise adjustment for
multiple testing. All analyses will be performed using
SPSS version 22.0 [56]. Castor Electronic Data Capture
(EDC) will be used to build electronic Case Report
Forms (eCRFs) for save and valid data collection.
Primary endpoint in the study will be HAD as mea-
sured with the Katz-ADL index score. For multivariable
analyses (General Linear models and log-linear models)
a custom 10:1 case-to-outcome ratio is utilized as a
maximum. Utilizing a repeated measures design, power
calculations imputing a conservative α level of 0.01
yielded a power of 95 % for associations of a small
effect-size (Cohen’s f = 0.069), whereas a power of 80 %
was established for associations with an effect-size of
0.058 (Cohen’s f ).Discussion
More than 30 % of the older patients experience
hospitalization-associated disability (HAD) after acute
hospitalization [1, 3, 4], which implies the loss of ability
to perform one or more of the basic ADLs [6]. HAD is
the leading cause of functional decline at older age [4].
With a higher number of older persons and an increas-
ing life expectancy, there is an urgent need to unravel
the potential mechanisms behind HAD as well as how
the mechanisms can be influenced. To our knowledge,
the Hospital-ADL study is the first study that investi-
gates cognitive, behavioral, psychosocial, physical, and
biological factors simultaneously. The current study will
provide novel information regarding possible underlying
mechanisms behind HAD within the critical period of
three months post hospitalization, which is expected to
lead to the development of interventions that can prevent
or restore HAD.
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